Recce Pharmaceuticals lands ethics approval for expanded UTI studies
Recce Pharmaceuticals receives Ethics Approval to expand R327 Faster Infusion, Phase I/II Clinical Trial
Recce Pharmaceuticals (ASX:RCE) gains ethics approval to expand phase I/II trial of R327
Recce Pharmaceuticals recruits outpatient nurses to drive “largest in Australia” diabetic foot infection clinical trial
Recce Pharmaceuticals (ASX:RCE) appoints outpatient nurses from Ascott
Recce Pharmaceuticals (ASX:RCE) secures sponsorship to attend BIO Korea 2023
ASX:RCE
ASX:RCE
Recce Pharmaceuticals Ltd attracts $1.8 million as it moves toward human clinical trials Recce Pharmaceuticals Ltd (ASX:RCE) has raised about $1.8 million from sophisticated and institutional investors…
Recce Pharmaceuticals locks
Recce Pharmaceuticals locks
In US patent for synthetic antibiotic to target growing superbug problem Recce Pharmaceuticals (ASX: RCE) has locked-in a US patent for its broad-spectrum synthetic antibiotics, paving the way for the…
Director Trades
Director Trades
A millennial director put his $100k into his own company rather than a house deposit It was millionaire’s row last week in small cap land, with four multi-million dollar trades and one that was pretty close…